News

MOH Welcomes Clinical Trials On Products Containing Cannabis Extract For Medical Use

KUALA LUMPUR, July 28 (Bernama) — The Ministry of Health (MOH) welcomes applications to conduct clinical trials on products containing cannabis extract for medical purposes as no such clinical trials are being carried out in the country so far, said Deputy Health Minister Datuk Dr Noor Azmi Ghazali.

He said the Dangerous Drugs Act 1952, the Poisons Act 1952 and the Sale of Drugs Act 1952 have already allowed the production of cannabis extract to be supplied, imported, sold, used for medical purposes, research, or clinical trials for medical purposes subject to the requirements provided by the acts.

He was responding to a question from Syed Saddiq Syed Abdul Rahman (MUDA-Muar) who wanted MOH to state the latest status on the legalisation and use of medical cannabis in Malaysia.

Elaborating, Dr Azmi said companies that have adequate scientific proof of the effectiveness of products containing cannabis extract for medical purposes can submit an application to register the products to Drug Control Authority under the ministry.

In addition, he said companies with medical cannabis products that have been approved abroad, can apply to have their products registered and marketed in Malaysia.

“The MOH does not reject studies on the effectiveness of medical cannabis, it is time we follow the steps of 40 countries that have used it to treat diseases including cancer, depression, and epilepsy, we are ready to look at this,” he said.

Meanwhile, on the proposal to separate interpretations of cannabis, medical cannabis, and hemp from a legal aspect, he said, the matter would depend on the findings of the main committee on the development of the cannabis and ketum industry for medical purposes set up by the ministry and tasked to study and formulate the direction of the industry’s development.

“Therefore the need to amend the Dangerous Drugs Act 1952 in connection with the control of cannabis and hemp including creating separate interpretations for cannabis and hemp depends on the Cabinet’s decision after reviewing the committee’s findings, taking into account the legal, socio-cultural, health, economy, Shariah law aspects and so on,” he added.

Sources: BERNAMA

Adib Mohd

Recent Posts

Maxim Rolls Out Partner-Driver Legalization Program to Elevate Compliance and Road Safety

Maxim, one of Malaysia’s leading e-hailing platforms, has officially introduced a Partner-Driver Legalization Program designed… Read More

8 minutes ago

Sabah Crowned Malaysia’s Favourite Destination, A Paradise of Peaks, Seas, and Culture Awaits!

Sabah, located in the north-eastern part of Borneo, has officially earned the title of Malaysia’s… Read More

22 minutes ago

Coca‑Cola Brings Back ‘Share a Coke’ Now With a Proudly Malaysian Twist

This Merdeka, Coca‑Cola is turning up the nostalgia and the local flavour. The iconic ‘Share… Read More

18 hours ago

11 Women, 8 Countries, 1 Dream: ASEAN-UK SAGE Women in STEM Scholarships 2025 Announced

Picture this: 11 brilliant women from across ASEAN are packing their bags, not just for… Read More

22 hours ago

L’Oréal Malaysia Celebrates 30 Years of Beauty Innovation and Impact

L’Oréal Groupe today marked its 30th anniversary in Malaysia, celebrating three decades of bringing world-class… Read More

22 hours ago

Smiles Are the New Flex, But 34% of Malaysians Still Hide Theirs

Smiles aren’t just cosmetic anymore they’re currency. But here’s the catch: 34% of people admit… Read More

23 hours ago

This website uses cookies.